U.S. pharma big copyright scrapped two experimental weight loss supplements past calendar year—a the moment-daily capsule, lotiglipron, on account of elevated liver enzymes as well as a twice-every day pill, danuglipron, resulting from strong side effects—but CEO Albert Bourla has reported the company is set to “Enjoy and gain” in the obesi… Read More